/LABS.TO
LABS.TO Stock - MediPharm Labs Corp.
Healthcare|Drug Manufacturers - Specialty & GenericTSX
$0.07+0.00%
+$0.00 (+0.00%) • Jan 14
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.45
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LABS.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.07 – $0.07
TARGET (TP)$0.08
STOP LOSS$0.06
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.71
52W High$0.12
52W Low$0.06
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $41.96M | $33.06M | $22.12M | $21.71M | $36.01M |
| Gross Profit | $12.80M | $5.86M | $-1,914,000 | $-15,246,000 | $-43,978,000 |
| Gross Margin | 30.5% | 17.7% | -8.7% | -70.2% | -122.1% |
| Operating Income | $-10,809,000 | $-18,252,000 | $-29,533,000 | $-48,916,000 | $-72,576,000 |
| Net Income | $-10,694,000 | $-13,083,000 | $-29,983,000 | $-54,801,000 | $-67,110,000 |
| Net Margin | -25.5% | -39.6% | -135.6% | -252.4% | -186.4% |
| EPS | $-0.03 | $-0.04 | $-0.11 | $-0.22 | $-0.48 |
Company Overview
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LABS.TOBeat Rate
0%
Last 18 quarters
Avg Surprise
-113.4%
EPS vs Estimate
Beats / Misses
0/15
3 met exactly
Latest EPS
$-0.01
Q4 2025
EPS Surprise History
Q4 23
-100.0%
$-0.01vs$-0.01
Q1 24
0.0%
$-0.01vs$-0.01
Q2 24
0.0%
$-0.01vs$-0.01
Q3 24
0.0%
$-0.01vs$-0.01
Q4 24
-212.5%
$-0.01vs$-0.00
Q1 25
No data
Q2 25
-194.1%
$-0.01vs$-0.00
Q4 25
-69.7%
$-0.01vs$-0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.00 | $-0.01 | -69.7% | ✗ MISS |
Q2 2025 | May 15, 2025 | $-0.00 | $-0.01 | -194.1% | ✗ MISS |
Q1 2025 | Mar 27, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 14, 2024 | $-0.00 | $-0.01 | -212.5% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2024 | May 15, 2024 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2024 | Mar 27, 2024 | $-0.01 | $-0.01 | 0.0% | = MET |
Q4 2023 | Nov 14, 2023 | $-0.01 | $-0.01 | -100.0% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.01 | $-0.01 | -33.3% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.01 | $-0.02 | -33.3% | ✗ MISS |
Q1 2023 | Mar 27, 2023 | $-0.01 | $-0.02 | -98.8% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-0.02 | $-0.08 | -300.0% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-0.03 | $-0.05 | -66.7% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-0.03 | $-0.07 | -133.3% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | $-0.03 | $-0.21 | -600.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about LABS.TO
What is LABS.TO's current stock price?
MediPharm Labs Corp. (LABS.TO) is currently trading at $0.07 per share. The stock has moved +0.00% today.
What is the analyst price target for LABS.TO?
No analyst price targets are currently available for this stock.
What sector is MediPharm Labs Corp. in?
MediPharm Labs Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the TSX exchange.
What is LABS.TO's market cap?
MediPharm Labs Corp. has a market capitalization of $0.03 billion, making it a small-cap company.
Does LABS.TO pay dividends?
No, MediPharm Labs Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADK.V
DIAGNOS Inc.
$0.31
Mkt Cap: $0.0B
AVCN.TO
Avicanna Inc.
$0.23
Mkt Cap: $0.0B
CWEB.TO
Charlotte's Web Holdings, Inc.
$0.51
Mkt Cap: $0.1B
GLAB.CN
Gemina Laboratories Ltd.
$0.06
Mkt Cap: $0.0B
GWAY.CN
Greenway Greenhouse Cannabis Corporation
$0.17
Mkt Cap: $0.0B
IZO.CN
Izotropic Corporation
$0.29
Mkt Cap: $0.0B
PINK.V
Perimeter Medical Imaging AI, Inc.
$0.35
Mkt Cap: $0.0B
ROMJ.V
Rubicon Organics Inc.
$0.50
Mkt Cap: $0.0B
RVX.TO
Resverlogix Corp.
$0.10
Mkt Cap: $0.0B
VM.V
Voyageur Pharmaceuticals Ltd.
$0.18
Mkt Cap: $0.0B
Explore stocks similar to LABS.TO for comparison